Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma
Despite the high probability of glaucoma-related blindness, its cause is not fully understood and there is no efficient therapeutic strategy for neuroprotection. Vascular factors have been suggested to play an important role in glaucoma development and progression. Previously, we have proven the neu...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2023
|
| Sorozat: | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
24 No. 17 |
| Tárgyszavak: | |
| doi: | 10.3390/ijms241713256 |
| mtmt: | 34117220 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/29893 |
| LEADER | 02724nab a2200325 i 4500 | ||
|---|---|---|---|
| 001 | publ29893 | ||
| 005 | 20240319081300.0 | ||
| 008 | 240319s2023 hu o 0|| eng d | ||
| 022 | |a 1661-6596 | ||
| 024 | 7 | |a 10.3390/ijms241713256 |2 doi | |
| 024 | 7 | |a 34117220 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a eng | ||
| 100 | 1 | |a Patkó Evelin Viktória | |
| 245 | 1 | 0 | |a Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma |h [elektronikus dokumentum] / |c Patkó Evelin Viktória |
| 260 | |c 2023 | ||
| 300 | |a 14 | ||
| 490 | 0 | |a INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |v 24 No. 17 | |
| 520 | 3 | |a Despite the high probability of glaucoma-related blindness, its cause is not fully understood and there is no efficient therapeutic strategy for neuroprotection. Vascular factors have been suggested to play an important role in glaucoma development and progression. Previously, we have proven the neuroprotective effects of pituitary adenylate-cyclase-activating polypeptide (PACAP) eye drops in an inducible, microbeads model in rats that is able to reproduce many clinically relevant features of human glaucoma. In the present study, we examined the potential protective effects of PACAP1-38 on the retinal vasculature and the molecular changes in hypoxia. Ocular hypertension was induced by injection of microbeads into the anterior chamber, while control rats received PBS. PACAP dissolved in vehicle (1 µg/drop) or vehicle treatment was started one day after the injections for four weeks three times a day. Retinal degeneration was assessed with optical coherence tomography (OCT), and vascular and molecular changes were assessed by immunofluorescence labeling. HIF1-α and VEGF-A protein levels were measured by Western blot. OCT images proved severe retinal degeneration in the glaucomatous group, while PACAP1-38 eye drops had a retinoprotective effect. Vascular parameters were deteriorated and molecular analysis suggested hypoxic conditions in glaucoma. PACAP treatment exerted a positive effect against these alterations. In summary, PACAP could prevent the severe damage to the retina and its vasculature induced by ocular hypertension in a microbeads model. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Szabó Edina |e aut |
| 700 | 0 | 1 | |a Váczy Alexandra |e aut |
| 700 | 0 | 1 | |a Molitor Dorottya |e aut |
| 700 | 0 | 1 | |a Tari Eniko |e aut |
| 700 | 0 | 1 | |a Li Lina |e aut |
| 700 | 0 | 1 | |a Csutak Adrienne |e aut |
| 700 | 0 | 1 | |a Tóth Gábor |e aut |
| 700 | 0 | 1 | |a Reglődi Dóra |e aut |
| 700 | 0 | 1 | |a Atlasz Tamás |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/29893/1/Patko23_IJMS_24-13256.pdf |z Dokumentum-elérés |